Literature DB >> 1435668

The management of acute diarrhea in children: oral rehydration, maintenance, and nutritional therapy. Centers for Disease Control and Prevention.

C Duggan1, M Santosham, R I Glass.   

Abstract

Worldwide, diarrhea remains one of the most common illnesses among children. In the United States, children < 5 years of age experience > 20 million episodes of diarrhea each year, leading to several million doctor visits, 200,000 hospitalizations, and approximately 400 deaths. Much of this morbidity is due to the dehydration associated with acute watery diarrhea. Consequently, the proper management of children with acute diarrhea is important for all practitioners as well as for parents of small children. The development of oral therapy for the rehydration and maintenance of children with dehydrating diarrhea has become the worldwide mainstay of national diarrheal control programs. More recently, proper nutrition for children with diarrhea is viewed as an important adjunct to therapy, whereas antibiotics and other drugs play only a limited role. Intravenous therapy remains essential for diarrheal episodes associated with severe dehydration. This document reviews the proper management of diarrhea among children. Particular attention is given to the use of oral therapy for rehydration and maintenance therapy for the dehydrated child and nutritional management. In the United States, the improved management of children with diarrhea could lead to a noticeable decrease in the number of children who are hospitalized or die as a result of diarrheal illness. This report contains recommendations prepared by the Centers for Disease Control and Prevention (CDC), with input from a panel of pediatric and diarrheal management experts, which are consistent with recommendations endorsed by the American Academy of Pediatrics.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1435668

Source DB:  PubMed          Journal:  MMWR Recomm Rep        ISSN: 1057-5987


  23 in total

Review 1.  Rotavirus infections: guidelines for treatment and prevention.

Authors:  U Desselberger
Journal:  Drugs       Date:  1999-09       Impact factor: 9.546

Review 2.  Microecologic approaches for traveler's diarrhea, antibiotic-associated diarrhea, and acute pediatric diarrhea.

Authors:  L V McFarland
Journal:  Curr Gastroenterol Rep       Date:  1999-08

Review 3.  Principles and Practice of Oral Rehydration.

Authors:  Sylvia Y Ofei; George J Fuchs
Journal:  Curr Gastroenterol Rep       Date:  2019-12-07

4.  Travellers' diarrhea in children.

Authors:  Pierre J Plourde
Journal:  Paediatr Child Health       Date:  2003-02       Impact factor: 2.253

5.  Risk factors and case management of acute diarrhoea in North Gondar Zone, Ethiopia.

Authors:  Rishi P Mediratta; Amsalu Feleke; Lawrence H Moulton; Sisay Yifru; R Bradley Sack
Journal:  J Health Popul Nutr       Date:  2010-06       Impact factor: 2.000

Review 6.  New developments in acute diarrhea.

Authors:  D I Mehta; E Lebenthal
Journal:  Curr Probl Pediatr       Date:  1994-03

7.  Efficacy of directly observed treatment of HIV infection: experience in AIDS welfare homes.

Authors:  I Tinoco; J A Girón-González; M T González-González; A Vergara de Campos; L Rodríguez-Félix; A Serrano; A Bascuñana
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-03-13       Impact factor: 3.267

8.  Viral gastroenteritis: Causes, pathophysiology, immunology, treatment, and epidemiology.

Authors: 
Journal:  Perspect Med Virol       Date:  2004-09-14

9.  Prevention of rotavirus gastroenteritis in infants and children: rotavirus vaccine safety, efficacy, and potential impact of vaccines.

Authors:  Aruna Chandran; Sean Fitzwater; Anjie Zhen; Mathuram Santosham
Journal:  Biologics       Date:  2010-08-09

Review 10.  Prevention of contrast-induced acute kidney injury: is simple oral hydration similar to intravenous? A systematic review of the evidence.

Authors:  Swapnil Hiremath; Ayub Akbari; Wael Shabana; Dean A Fergusson; Greg A Knoll
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.